242 related articles for article (PubMed ID: 8643604)
21. Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance.
Kellam P; Boucher CA; Tijnagel JM; Larder BA
J Gen Virol; 1994 Feb; 75 ( Pt 2)():341-51. PubMed ID: 7509370
[TBL] [Abstract][Full Text] [Related]
22. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.
Richman DD; Havlir D; Corbeil J; Looney D; Ignacio C; Spector SA; Sullivan J; Cheeseman S; Barringer K; Pauletti D
J Virol; 1994 Mar; 68(3):1660-6. PubMed ID: 7509000
[TBL] [Abstract][Full Text] [Related]
23. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
Naeger LK; Margot NA; Miller MD
Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy.
Loveday C; Kaye S; Tenant-Flowers M; Semple M; Ayliffe U; Weller IV; Tedder RS
Lancet; 1995 Apr; 345(8953):820-4. PubMed ID: 7534858
[TBL] [Abstract][Full Text] [Related]
25. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
Kuritzkes DR; Sevin A; Young B; Bakhtiari M; Wu H; St Clair M; Connick E; Landay A; Spritzler J; Kessler H; Lederman MM
J Infect Dis; 2000 Feb; 181(2):491-7. PubMed ID: 10669331
[TBL] [Abstract][Full Text] [Related]
26. Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model.
Stilianakis NI; Boucher CA; De Jong MD; Van Leeuwen R; Schuurman R; De Boer RJ
J Virol; 1997 Jan; 71(1):161-8. PubMed ID: 8985335
[TBL] [Abstract][Full Text] [Related]
27. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.
Sheehy N; Desselberger U
J Gen Virol; 1993 Feb; 74 ( Pt 2)():223-8. PubMed ID: 7679140
[TBL] [Abstract][Full Text] [Related]
28. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro.
Harrigan PR; Bloor S; Larder BA
J Virol; 1998 May; 72(5):3773-8. PubMed ID: 9557659
[TBL] [Abstract][Full Text] [Related]
29. Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates.
Nájera I; Richman DD; Olivares I; Rojas JM; Peinado MA; Perucho M; Nájera R; López-Galíndez C
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1479-88. PubMed ID: 7534096
[TBL] [Abstract][Full Text] [Related]
30. The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA.
Kaye S; Comber E; Tenant-Flowers M; Loveday C
AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1221-5. PubMed ID: 8573378
[TBL] [Abstract][Full Text] [Related]
31. Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates.
Boucher CA; van Leeuwen R; Kellam P; Schipper P; Tijnagel J; Lange JM; Larder BA
Antimicrob Agents Chemother; 1993 Jul; 37(7):1525-30. PubMed ID: 8103317
[TBL] [Abstract][Full Text] [Related]
32. Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1.
Leriche-Guérin K; Trabaud MA; Cotte L; Bissuel F; Deruelle E; Rougier P; Trépo C
Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):660-8. PubMed ID: 9352259
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.
Trabaud MA; Leriche-Guerin K; Regis C; Bordes I; Cotte L; Detmer J; Kolberg J; Ritter J; Trépo C
J Med Virol; 2000 Jul; 61(3):352-9. PubMed ID: 10861645
[TBL] [Abstract][Full Text] [Related]
34. A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine.
Kaye S; Loveday C; Tedder RS
J Med Virol; 1992 Aug; 37(4):241-6. PubMed ID: 1383414
[TBL] [Abstract][Full Text] [Related]
35. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
[TBL] [Abstract][Full Text] [Related]
36. Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance.
Kellam P; Larder BA
J Virol; 1995 Feb; 69(2):669-74. PubMed ID: 7529334
[TBL] [Abstract][Full Text] [Related]
37. Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
Izopet J; Bicart-See A; Pasquier C; Sandres K; Bonnet E; Marchou B; Puel J; Massip P
J Med Virol; 1999 Dec; 59(4):507-11. PubMed ID: 10534734
[TBL] [Abstract][Full Text] [Related]
38. Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents.
Wilson CC; Wong JT; Girard DD; Merrill DP; Dynan M; An DD; Kalams SA; Johnson RP; Hirsch MS; D'Aquila RT
J Infect Dis; 1995 Jul; 172(1):88-96. PubMed ID: 7541065
[TBL] [Abstract][Full Text] [Related]
39. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients.
Mohri H; Singh MK; Ching WT; Ho DD
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):25-9. PubMed ID: 7678340
[TBL] [Abstract][Full Text] [Related]
40. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
